Cardiovascular Systems’ (NSDQ:CSII) revenues soared in its 3rd quarter, driven primarily by the popularity of the company’s Stealth 360 device, a peripheral artery disease treatment system.
Q1
Wright Medical jumps 9% on Q1 earnings beat
Wright Medical (NSDQ:WMGI) posted better-than-expected earnings yesterday for the 1st quarter, prompting investors to send its share price up more than 9% today.
Smith & Nephew slides on missed Q1 earnings mark
Investors on both sides of the Atlantic today reacted to lower-than-expected 1st-quarter earnings from Smith & Nephew (FTSE:SN, NYSE:SNN) today by sending share prices down nearly 2%.
Teleflex gains on strong Q1, Intuitive Surgical supply deal
Endo Health posts Q1 loss on $830M AMS mesh settlement
Endo Health Solutions (NSDQ:ENDP) said it struck an $830 million deal to settle thousands of lawsuits over its American Medical Systems pelvic mesh products.
Abiomed reveals HHS probe into provider payments
Weather-induced FDA delay hits Staar Surgical’s bottom line
California-based STAAR Surgical (NSDQ:STAA) swung hard to a 1st-quarter loss after storm-related regulatory delays cost the company its bottom line.
Legal loss pushes NuVasive to Q1 red
NuVasive Inc. (NSDQ:NUVA) swung to a 1st-quarter loss after a jury ruled against it in a trademark infringement battle with NeuroVision, prompting the medical device company to lower its 2014 earnings outlook and investors to pare more than 2% from its share price.
Patent battle takes a chunk out of Varian’s bottom line
Radiosurgery devices maker Varian Medical (NYSE:VAR) posted a tough quarter, with sales up a modest 1.3% and earnings sucked up by legal charges in its 2nd quarter.